References
- Laroui S, Balduyck M, Mizon C, Selloum L, Mizon J. Plasma proteins immunologically related to inter-α-trypsin inhibitor. Biochim Biophys Acta 1988; 953: 263–8
- Ödum L, Hansen-Nord G, Byrjalsen I. Human inter-α-trypsin inhibitor and immunologically related inhibitors investigated by qauntitative immunoelectrophoresis. II. Pathological conditions. Clin Chim Acta 1987; 162: 189–98
- Maruyama M, Sumi H, Akazawa K, Mihara H. Marked increase of plasma acid stable/soluble trypsin inhibitor in hemodialysis patients. Clin Chim Acta 1984; 138: 205–13
- Faarvang HJ. The excretion of trypsin inhibitor in urine during normal pregnancy. Acta Endocrinol 1959; 31: 117–22
- Dillard G HL. The trypsin inhibitor of the urine in health and disease. J Clin Lab Med. 1950; 36: 266–71
- Toki S, Sumi H. Urinary trypsin inhibitor and urokinase activities in renal diseases. Acta Haemat 1982; 67: 109–13
- Gosset D, Mizon C, Savinel P, Balduyck M, Boniface B, Hatron P Y, Mizon J, Devulder B. Intérět clinique de la détermination de ľactivité antitrypsique urinaire. Presse Med 1988; 17: 329–32
- McKeehan W, Sakagami Y, HoshiMc H., Keehan K. Two apparent human endothelial cell growth factors from human hepatoma cells are tumour-associated proteinase inhibitors. J Biol Chem 1986; 261: 5378–83
- Salier J-P, Sesboüé R, Vercaigne D, Bourguignon J, Martin J-P. Inter-α-trypsin inhibitor (ITI): use of new antisera for quantitative studies and discrete quantitation of ITI and its derivates. Anal Biochem 1983; 133: 336–43
- Yoshida E, Sumi H, Maruyama M, Tsushima H, Matsuoka Y, Sugiki M, Mihara H. Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malignant human tissues. Cancer 1989; 64: 860–9
- Balduyck M, Davril M, Mizon C, Smyrlaki M, Hayem A, Mizon J. Human urinary proteinase inhibitor: inhibitory properties and interaction with bovine trypsin. Biol Chem Hoppe-Seyler 1985; 366: 9–14
- Jönsson B-M, Loftier C, Ohlsson K. Human granulocyte elastase is inhibited by the urinary trypsin inhibitor. Hoppe-Seyler's Z Physiol Chem 1982; 363: 1167–75
- Schreitmüller T, Hochstrasser K, Reisinger P, Wachter E, Gebhard W. cDNA of hunan inter-a-trypsin inhibitor discloses three different proteins. Biol Chem Hoppe-Seyler 1987; 368: 963–70
- Fraker P J, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849–57
- Greenwood F C, Hunter W M, Glover JS. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–23
- össon-Bcrling B-MJ., Ohlsson K, Rosengren M. Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine. Biol Chem Hoppe-Seyler 1989; 370: 1157–61
- Strober W, Waldman TA. The role of the kidney in the metabolism of plasma proteins. Nephron 1974; 13: 35–66
- Jösson B-M, Ohlsson K. Interactions of the complex between human urinary trypsin inhibitor and human leukocyte elastase with α1 proteinase inhibitor and α2 macroglobulin. Hoppe-Seyler's Z Physiol Chem 1984; 365: 1403–8
- Eddeland A, Ohlsson K. Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro. Scand J Clin Lab Invest 1978; 38: 507–15
- Fryksmark U, Ohlsson K, Rosengren M, Tegner H. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors α1-proteinase inhibitor and α2-macroglobulin. Hoppe-Seyler's Z Physiol Chem 1983; 364: 793–800
- Sugiki M, Sumi H, Maruyama M, Yoshida E, Mihara H. Clearance and distribution of acid-stable trypsin inhibitor (ASTI). Enzyme 1989; 42: 31–8